No connection

Search Results

NMR

NEUTRAL
$8.06 Live
Nomura Holdings, Inc. · NYSE
Target $9.35 (+16.0%)
$5.48 52W Range $9.58

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated May 01, 2026
Market cap
$23.27B
P/E
10.75
ROE
10.1%
Profit margin
16.7%
Debt/Equity
9.17
Dividend yield
5.11%

AI Analysis

AI-powered fundamental assessment

Confidence
85%
Nomura Holdings presents a stark contrast between attractive valuation and poor operational health, highlighted by a weak Piotroski F-Score of 2/9. While the stock trades significantly below its Graham Number ($11.50) and Intrinsic Value ($10.31), the fundamental health metrics are concerning. Strong revenue growth and a healthy dividend yield are offset by extreme leverage (Debt/Equity of 9.17) and a consistent track record of missing earnings estimates. The current price of $8.06 suggests a value play, but the lack of operational momentum warrants a neutral stance.

Key Strengths

Trading at a significant discount to Graham Number ($11.50) and Intrinsic Value ($10.31)
Strong dividend yield of 5.11% with a sustainable payout ratio of 21.73%
Robust year-over-year revenue growth of 27.50%
Attractive PEG ratio of 0.81, suggesting growth is undervalued relative to price
Low Price-to-Book ratio of 1.03, indicating the stock is trading near its book value

Key Risks

Critically low Piotroski F-Score (2/9) indicating deteriorating financial health
Extreme leverage with a Debt/Equity ratio of 9.17
Poor earnings reliability, beating estimates in only 1 of the last 4 quarters
Bearish technical trend (0/100) despite long-term price appreciation
Very low Return on Assets (ROA) of 0.63%, indicating inefficient asset utilization
AI Fair Value Estimate
Based on comprehensive analysis
$10.1
+25.3% above current price

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall
55
Moderate
Value
85
Future
50
Past
40
Health
20
Dividend
80
AI Verdict
Value Trap Risk
Key drivers: Deep valuation discount, Poor operational health (F-Score), High leverage, Strong dividend
Confidence
90%
Value
85/100

Ref P/E, PEG, Graham Number

Positives
  • P/E of 10.75 is low
  • Price is below Graham Number
  • PEG < 1
Watchpoints
  • Forward P/E is higher than current P/E, suggesting expected earnings contraction
Future
50/100

Ref Growth rates

Positives
  • High YoY Revenue growth (27.5%)
Watchpoints
  • Negative Q/Q EPS growth (-20%)
  • Sluggish YoY Earnings growth (4.5%)
Past
40/100

Ref Historical trends

Positives
  • Strong 1Y and 3Y price performance
Watchpoints
  • Consistent earnings misses
  • Average surprise of -7.06% over last 4 quarters
Health
20/100

Ref Altman Z-Score, Piotroski F-Score

Positives
  • Current ratio > 1.5
Watchpoints
  • Piotroski F-Score of 2/9
  • Debt/Equity of 9.17
Dividend
80/100

Ref Yield, Payout

Positives
  • 5.11% yield
  • Low payout ratio (21.73%)
Watchpoints
  • Lack of 5-year average yield data for stability check

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price
$8.06
Analyst Target
$9.35
Upside/Downside
+16.0%

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for NMR and closest competitors.

Updated 2026-04-30
NMR
Nomura Holdings, Inc.
Primary
5Y
+60.7%
3Y
+146.2%
1Y
+45.2%
6M
+14.2%
1M
+2.1%
1W
-2.5%
SOF
SoFi Technologies, Inc.
Peer
5Y
+5.3%
3Y
+194.7%
1Y
+39.1%
6M
-42.0%
1M
+21.2%
1W
-2.5%
L
Loews Corporation
Peer
5Y
+103.8%
3Y
+97.0%
1Y
+31.1%
6M
+14.4%
1M
+6.2%
1W
+0.8%
KEY
KeyCorp
Peer
5Y
+26.7%
3Y
+130.1%
1Y
+54.4%
6M
+27.5%
1M
+13.2%
1W
-0.6%
TW
Tradeweb Markets Inc.
Peer
5Y
+42.0%
3Y
+61.5%
1Y
-17.4%
6M
+4.2%
1M
-3.9%
1W
-1.9%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

P/E Ratio
10.75
Forward P/E
14.39
PEG Ratio
0.81
P/B Ratio
1.03
P/S Ratio
0.01
EV/Revenue
-6.04
EV/EBITDA
N/A
Market Cap
$23.27B

Profitability

Profit margins and return metrics

Profit Margin 16.71%
Operating Margin 18.66%
Gross Margin 78.31%
ROE 10.07%
ROA 0.63%

Growth

Revenue and earnings growth rates

Revenue Growth +27.5%
Earnings Growth +4.5%
Q/Q Revenue Growth +8.6%
Q/Q Earnings Growth +2.7%

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity
9.17
High debt
Current Ratio
1.57
Good
Quick Ratio
1.56
Excellent
Cash/Share
$16756.9

Quarterly Earnings History

EPS performance vs analyst estimates

2026-07-28
$N/A
2026-04-24
$0.16
-25.7% surprise
2026-01-30
$0.2
-14.5% surprise
2025-10-28
$0.2
+19.0% surprise

Financial Services Sector Comparison

Comparing NMR against 956 companies in the Financial Services sector (153 bullish, 417 neutral, 386 bearish)
P/E Ratio
10.75
This Stock
vs
35.14
Sector Avg
-69.4% (Discount)
Return on Equity (ROE)
10.07%
This Stock
vs
0.3%
Sector Avg
+3234.4% (Excellent)
Profit Margin
16.71%
This Stock
vs
89.71%
Sector Avg
-81.4% (Weaker)
Debt to Equity
9.17
This Stock
vs
1.28
Sector Avg
+619.5% (Higher)
Revenue Growth
27.5%
This Stock
vs
33.39%
Sector Avg
-17.7% (Slower)
Current Ratio
1.57
This Stock
vs
2.99
Sector Avg
-47.3% (Weaker)

Similar Companies

Peer comparison within the same industry

SEC Filings

Recent regulatory filings from the SEC EDGAR database

20-F
ANNUAL REPORT
2025-06-23

NMR filed its annual report on Form 20-F on June 23, 2025. Due to the limited information provided, specific financial highlights and risk factors are not available for summary.

20-F
ANNUAL REPORT
2024-06-26

NMR submitted its annual report on Form 20-F on June 26, 2024, providing a comprehensive overview of its yearly financial performance. The filing contains the company's audited financial statements and detailed disclosures regarding its operational and market risks.

Data sourced from SEC EDGAR. AI summaries generated automatically.

Wall Street Analysts

Professional analyst ratings and price targets

Consensus
HOLD
1 analysts
JP Morgan
2026-03-19
up
Neutral Overweight

Past News Coverage

Recent headlines mentioning NMR from our newsroom.

Newest → oldest
TradingGPT V2 Copilot
Fundamentals • Valuation • Risk
Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends
Home
Terminal
AI Chat
Markets
Profile